Literature DB >> 30263357

Synergistic antimicrobial activity of bacteriophages and antibiotics against Staphylococcus aureus.

Ara Jo1, Tian Ding2, Juhee Ahn1.   

Abstract

This study was designed to assess the synergistic antimicrobial effect of phages combined with antibiotics against Staphylococcus aureus. The phage-antibiotic synergy (PAS) effect was evaluated using the fractional inhibitory concentration (FIC) and flow cytometric analysis. The determined minimum inhibitory concentration (MIC) values varied from 0.125 to 128 μg/mL for S. aureus KACC 13236 (SAS) and from 0.25 to >256 μg/mL for S. aureus CCARM 3080 (SAR). The PAS effect was more pronounced in SAS treated with phage SA11 in the presence of cefoxitin (FIC=0.62), chloramphenicol (FIC=0.54), and polymyxin B (FIC=0.38). SAS and SAR cells were injured when exposed to asublethal concentration of ciprofloxacin, whereas these cells were highly susceptible to the phage-antibiotic combined treatment, showing 96% of relative percentages of injured and dead cells. The results suggest that the combined treatment of phages and antibiotics can be used to improve antimicrobial efficacy against antibiotic-resistant bacteria.

Entities:  

Keywords:  Staphylococcus aureus; antibiotic resistance; bacteriophage; fractional inhibitory concentration; phage-antibiotic synergy

Year:  2016        PMID: 30263357      PMCID: PMC6049171          DOI: 10.1007/s10068-016-0153-0

Source DB:  PubMed          Journal:  Food Sci Biotechnol        ISSN: 1226-7708            Impact factor:   2.391


  20 in total

1.  Meeting the challenges of methicillin-resistant Staphylococcus aureus with outpatient parenteral antimicrobial therapy.

Authors:  Alan D Tice; Susan J Rehm
Journal:  Clin Infect Dis       Date:  2010-09-15       Impact factor: 9.079

Review 2.  Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.

Authors:  Ben Burrowes; David R Harper; Joseph Anderson; Malcolm McConville; Mark C Enright
Journal:  Expert Rev Anti Infect Ther       Date:  2011-09       Impact factor: 5.091

3.  Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli.

Authors:  K Hirai; H Aoyama; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

4.  Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity.

Authors:  Fatima Kamal; Jonathan J Dennis
Journal:  Appl Environ Microbiol       Date:  2014-12-01       Impact factor: 4.792

5.  Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria.

Authors:  Ido Yosef; Miriam Manor; Ruth Kiro; Udi Qimron
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-18       Impact factor: 11.205

Review 6.  Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool.

Authors:  Zuzanna Kaźmierczak; Andrzej Górski; Krystyna Dąbrowska
Journal:  Viruses       Date:  2014-07-01       Impact factor: 5.048

Review 7.  Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities.

Authors:  Anahit Penesyan; Michael Gillings; Ian T Paulsen
Journal:  Molecules       Date:  2015-03-24       Impact factor: 4.411

8.  Synergistic action of gentamicin and bacteriophage in a continuous culture population of Staphylococcus aureus.

Authors:  Amy E Kirby
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

9.  Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth.

Authors:  André M Comeau; Françoise Tétart; Sabrina N Trojet; Marie-Françoise Prère; H M Krisch
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

10.  Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms.

Authors:  Lindsey B Coulter; Robert J C McLean; Rodney E Rohde; Gary M Aron
Journal:  Viruses       Date:  2014-10-03       Impact factor: 5.048

View more
  11 in total

Review 1.  Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.

Authors:  Sabrina Royer; Aléxia Pinheiro Morais; Deivid William da Fonseca Batistão
Journal:  Arch Microbiol       Date:  2021-01-20       Impact factor: 2.552

2.  PhageScore-based analysis of Acinetobacter baumannii infecting phages antibiotic interaction in liquid medium.

Authors:  Bartłomiej Grygorcewicz; Marta Roszak; Rafał Rakoczy; Adrian Augustyniak; Maciej Konopacki; Joanna Jabłońska; Natalia Serwin; Elżbieta Cecerska-Heryć; Marian Kordas; Katarzyna Galant; Barbara Dołęgowska
Journal:  Arch Microbiol       Date:  2022-06-24       Impact factor: 2.552

3.  WPI Hydrogels with a Prolonged Drug-Release Profile for Antimicrobial Therapy.

Authors:  Valentina O Plastun; Ekaterina S Prikhozhdenko; Olga I Gusliakova; Svetlana V Raikova; Timothy E L Douglas; Olga A Sindeeva; Oksana A Mayorova
Journal:  Pharmaceutics       Date:  2022-06-04       Impact factor: 6.525

4.  The Combination of Salmonella Phage ST-3 and Antibiotics to Prevent Salmonella Typhimurium In Vitro.

Authors:  Min Lu; Bingxin Liu; Wenbin Xiong; Xinchun Liu
Journal:  Curr Microbiol       Date:  2022-10-21       Impact factor: 2.343

Review 5.  Bacteriophage therapy in aquaculture: current status and future challenges.

Authors:  Ruyin Liu; Ganghua Han; Zong Li; Shujuan Cun; Bin Hao; Jianping Zhang; Xinchun Liu
Journal:  Folia Microbiol (Praha)       Date:  2022-03-19       Impact factor: 2.629

Review 6.  Therapeutics and delivery vehicles for local treatment of osteomyelitis.

Authors:  Leah H Cobb; Emily M McCabe; Lauren B Priddy
Journal:  J Orthop Res       Date:  2020-04-21       Impact factor: 3.494

7.  Synergistic bactericidal activity of a naturally isolated phage and ampicillin against urinary tract infecting Escherichia coli O157.

Authors:  Zahra Moradpour; Nesa Yousefi; Dorna Sadeghi; Abdollah Ghasemian
Journal:  Iran J Basic Med Sci       Date:  2020-02       Impact factor: 2.699

8.  Aztreonam Lysine Increases the Activity of Phages E79 and phiKZ against Pseudomonas aeruginosa PA01.

Authors:  Carly M Davis; Jaclyn G McCutcheon; Jonathan J Dennis
Journal:  Microorganisms       Date:  2021-01-12

9.  Characterization of a Novel Bacteriophage Henu2 and Evaluation of the Synergistic Antibacterial Activity of Phage-Antibiotics.

Authors:  Xianghui Li; Tongxin Hu; Jiacun Wei; Yuhua He; Abualgasim Elgaili Abdalla; Guoying Wang; Yanzhang Li; Tieshan Teng
Journal:  Antibiotics (Basel)       Date:  2021-02-09

Review 10.  Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics?

Authors:  Prasanth Manohar; Belinda Loh; Sudarsanan Athira; Ramesh Nachimuthu; Xiaoting Hua; Susan C Welburn; Sebastian Leptihn
Journal:  Front Microbiol       Date:  2020-06-26       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.